Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. The European Commission Network on HIV Infection and Hepatitis in Prison.
about
Survey of French prison found that injecting drug use and tattooing occurred.Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey.Syringe availability as HIV prevention: a review of modalities.Meta-analysis of drug-related deaths soon after release from prison.Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).Loss of virus-specific T-cell responses in HCV exposed uninfected injection drug users with drug rehabilitation.The Effectiveness of Harm Reduction Programs in Seven Prisons of Iran.Mental health in prison populations. A review--with special emphasis on a study of Danish prisoners on remand.Impact of opioid substitution therapy for Scotland's prisoners on drug-related deaths soon after prisoner release.Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial.Measuring the gap: from Home Office to the National Health Service in the provision of a one-stop shop sexual health service in a female prison in the UK.Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.The political and scientific challenges in evaluating compulsory drug treatment centers in Southeast AsiaEvaluation of an e-learning package to improve understanding of blood-borne viruses amongst prison staff in Wales, UK.Drug use in prisons in Kyrgyzstan: a study about the effect of health promotion among prisoners.Drugs in British prisons. Policies need outside scrutiny if they are to do more good than harm.Detection of antibodies against hepatitis C virus in saliva: a marker of viral replication.Drug use and initiation in prison: results from a national prison survey in England and Wales.Longitudinal study on the prevalence of benzodiazepine (mis)use in a prison: importance of the analytical strategy.Persistence of drug use during imprisonment: relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine and amphetamine in prison.Proportional hazards model for interval-censored failure times and time-dependent covariates: application to hazard of HIV infection of injecting drug users in prison.Drugs, prisons, and harm reduction.Injecting Drug Use Amongst Inmates in Greek PrisonsDrug Use and Its Correlates in an Australian Prisoner Population
P2860
Q33789325-A01875CE-BE8C-4F49-B877-085389651697Q33947547-7E7AF86D-A5C3-4C50-9122-D3376BD2F029Q34025172-DE4DDAB2-46E5-4538-B2CE-7747A4E7DB9DQ34204943-FF60F81E-A658-415C-BAC5-53A30CD209FBQ34464990-979E129F-B8DB-4435-8B11-B0ABE5A6AFBAQ34764010-EB3237F3-3889-4A33-83CE-26D6B7A12A66Q35639306-0C2B2E26-7E38-40C7-B2BB-EE50A35C1547Q35901501-8181DF1F-F51D-4C4B-AE6A-1DD51D3A2B55Q36554497-6A915966-6175-482E-A6DC-E1E4B7FCF019Q37225942-40179F43-E724-4EDD-8AB2-3E567C7F5D85Q37251516-F50CC57B-47FA-4BC2-9289-74F6F599C6AAQ37343391-1645C6CF-290F-4EFB-87E7-255BD17C4E78Q37579790-4B5F060F-375A-4FDF-9E76-0FA0838F6430Q39030117-13646EA9-AE05-4BFF-84A7-EE2BD7657D21Q42594475-83F62288-8DE9-42BB-94BC-187887BDE6DEQ42756723-4621FF9F-0939-47E4-90F4-17F76916E20DQ42996543-239D2EB5-7E08-4A62-95C8-C8F912055113Q44242638-3117E89E-6B19-4697-8261-C7B8FFC2D8CDQ44602496-2154A9EE-BB44-42DD-A20B-F997492759D0Q50721453-DC85DB57-3786-4823-BF07-48B630273A1FQ52060979-76ADD3F5-CC7A-48D7-BD1E-DDB80FCCD8A2Q52089193-EC83E0E0-5F07-4A0F-B441-84D86E519570Q58126427-4C5C7592-60EF-458B-AD36-92484CC562C6Q58298207-4EA60B3E-038E-49BF-839B-872B8A3C36C7
P2860
Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. The European Commission Network on HIV Infection and Hepatitis in Prison.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
name
Harm reduction measures and in ...... ction and Hepatitis in Prison.
@ast
Harm reduction measures and in ...... ction and Hepatitis in Prison.
@en
Harm reduction measures and in ...... ction and Hepatitis in Prison.
@nl
type
label
Harm reduction measures and in ...... ction and Hepatitis in Prison.
@ast
Harm reduction measures and in ...... ction and Hepatitis in Prison.
@en
Harm reduction measures and in ...... ction and Hepatitis in Prison.
@nl
prefLabel
Harm reduction measures and in ...... ction and Hepatitis in Prison.
@ast
Harm reduction measures and in ...... ction and Hepatitis in Prison.
@en
Harm reduction measures and in ...... ction and Hepatitis in Prison.
@nl
P2093
P356
P1433
P1476
Harm reduction measures and in ...... ction and Hepatitis in Prison.
@en
P2093
P356
10.1136/BMJ.315.7099.21
P407
P577
1997-07-01T00:00:00Z